Post-traumatic stress disorder is usually described through what people feel – fear, anxiety, and intrusive memories. But new research suggests the effects run much deeper.
A recent study has identified a set of routine blood markers linked to PTSD, pointing to measurable changes across the body and offering a new way to understand how trauma affects long-term health.
Blood reveals PTSD patterns
Across a large collection of stored patient samples and medical records, the same pattern of altered lab values appeared alongside PTSD.
Working within that dataset, Younga Heather Lee, Ph.D., at Mass General Brigham, documented that these routine measurements consistently aligned with both inherited risk and diagnosed PTSD.
Those signals held across cholesterol, glucose, liver function, and blood cell counts, showing that the pattern extends beyond any single organ.
Such convergence points to a body-wide footprint of PTSD, setting up the need to understand how these changes unfold and what they mean for long-term health.
Trauma affects more than memory
PTSD can follow terrifying events and keep the body’s danger response active long after the threat has passed.
When that response stays switched on, stress hormones, sleep disruption, and inflammation can push organs away from normal balance.
Symptoms may include flashbacks, avoidance, poor sleep, and feeling on edge, but those experiences often bring physical wear too.
Blood tests cannot capture fear or memory, yet they may show how long-term stress has changed the body’s chemistry.
Routine labs show hidden stress
Routine lab work gave the team a practical path because many patients already have these results in medical records.
The researchers checked 241 distinct blood and chemistry measurements, then looked for markers tied to both inherited PTSD risk and recorded diagnosis.
Sixteen markers survived that double test, including cholesterol, glucose, liver readings, blood cell counts, and other common measures.
Because these results come from everyday care, future validation could move faster than tests requiring special equipment.
PTSD affects the whole body
Cholesterol and glucose point toward heart and metabolism stress, where the body handles fuel and blood vessel health.
Liver markers included albumin, a protein that helps hold fluid in the blood and carries hormones and medicines.
Another liver signal, bilirubin, forms when the body breaks down old red blood cells.
Blood cell counts added immune and clotting clues, showing that PTSD-linked changes did not cluster in one organ.
Genetics clarify PTSD effects
A genetic score helped separate body changes that may follow PTSD from traits that merely sit beside it.
That polygenic risk score, a DNA-based estimate built from many inherited differences, captured inherited vulnerability rather than a single PTSD gene.
A second method, Mendelian randomization, uses natural genetic differences to test which direction a health effect may run.
Those analyses supported PTSD as the likely upstream driver for several liver, cholesterol, and blood-clotting changes.
Body-wide signals emerge
The pattern fits a body-wide picture rather than one isolated pathway or one stray lab abnormality.
Lower protective cholesterol and higher fat-carrying cholesterol suggested stress on the system that manages fats in the blood.
Liver and immune markers widened the concern because they sit near chemical processing, infection defense, and chronic inflammation.
“This multi-system impact helps us understand why untreated PTSD can have such devastating effects on patients’ overall health,” Lee said.
Rethinking PTSD care
For doctors, the practical promise lies in using familiar tests to spot patients who need broader follow-up.
A PTSD visit could eventually include closer checks of cholesterol, glucose, liver health, and blood counts.
Abnormal results would not prove that trauma caused the problem, but they could trigger earlier prevention for chronic disease.
That approach treats PTSD as a condition with mental symptoms and physical consequences, not as two separate stories.
Findings need broader testing
The findings still need testing in larger groups with more racial, ethnic, social, and geographic diversity.
All participants in the main analysis had European ancestry, so the results may miss patterns in other populations.
Medical records can also undercount PTSD because many people never receive a diagnosis or avoid care.
Until validation is complete, clinicians should use these markers as research clues rather than stand-alone screening tools.
What comes next for PTSD care
For patients, the strongest message may be that trauma can leave marks beyond thoughts and mood.
A measurable body signal can make suffering feel less dismissed and help clinicians explain related health risks.
Better monitoring may also help people choose treatment earlier, before stress-linked wear turns into long-term disease.
Still, blood work should support therapy, medication, sleep care, and social support rather than replace them.
The new work ties genetic risk, clinical diagnosis, and routine lab results into a unified picture of PTSD’s physical effects across the body.
The next challenge is practical: showing that these markers can guide better care for real patients without reducing PTSD to a single blood-based measure.
The study is published in Molecular Psychiatry.
—–
Like what you read? Subscribe to our newsletter for engaging articles, exclusive content, and the latest updates.
Check us out on EarthSnap, a free app brought to you by Eric Ralls and Earth.com.
—–